Debt issuance costs expensed under fair value option
-
-
1,395,166
143,000
Net change in employee benefit liability
11,337
6,610
-
-
Interest expense recognized on preferred obligation related to orbit transaction (related party)
0
67,737
103,299
-
Settlement of transaction costs through reduction of receivable
-
-
-150,000
-
Equity in losses of unconsolidated affiliates (related party)
-
-
30,175
-
Change in fair value of warrant liabilities
-829,415
-11,396,260
12,612,546
1,392,598
Loss on issuance of warrants and related costs
-18,498
-8,206,193
-
-
Change in fair value of debt
-393,246
-8,279,246
-
-
Loss on issuance of debt
0
-11,661,274
-
-
Gain on initial recognition of tekne investment
0
84,000
-
-
Change in fair value of investments
3,087,260
36,285
-
-
Gain on issuance of syme bonds (related party)
0
49,514
-
-
Change in fair value of syme bonds (related party)
-95,206
33,038
-
-
Change in fair value of contingent consideration (including 351,042 and nil for the three months ended june 30, 2026 and 2025, respectively, and 46,661 and nil for the six months ended june 30, 2026 and 2025, respectively, with related parties)
368,523
-300,364
-
-
Change in fair value of derivative liability (including nil and nil for the three months ended june 30, 2026 and 2025, respectively, and 4,909,820 and nil for the six months ended june 30, 2026 and 2025, respectively, with related parties)
0
-4,909,820
0
0
Change in fair value of convertible notes receivable (including 174,100 and nil for the three months ended june 30, 2026 and 2025, respectively, and 393,100 and nil for the six months ended june 30, 2026 and 2025, respectively, with related parties)
288,535
1,073,803
-1,624,078
-1,044,294
Remeasurement of subscription for orbit shares (related party)
0
-1,189,837
-
-
Change in fair value of notes payable (including 847,646 and nil with related parties, respectively)
-
-
2,405,533
44,800
Remeasurement of orbit equity method investment (related party)
0
59,408
-
-
Change in fair value of sepa liability
-1,244,414
-228,935
-1,589,226
646,443
Change in fair value of claims settlement liability
-
-
0
2,584,724
Loss on issuance of warrants
-
-
0
-8,756,303
Loss on issuance of notes payable
-
-
-2,062,500
-443,466
Loss on issuance of sepa
-
-
0
0
Loss on extinguishment of accounts payable (including 290,676 and nil with related parties, respectively)
-
-
1,151,623
-6,513,554
Loss on extinguishment of notes payable (including 2,840,115 and 1,491,666 with related parties, respectively)
-
-
0
-3,265,002
Loss on settlement of claims liability, net
-
-
395,379
-
Sepa fees and issuance costs
-
-
-1,043,836
-28,451
Gain on sale of intellectual property intangible assets
-
-
0
0
Loss on impairment of inventories, property and equipment and operating lease right-of-use asset
-
-
0
0
Accounts receivable
192,519
-293,562
-
-
Interest expense recognized on remeasurement of preferred stock liability
-
-
0
0
Inventories
-48,005
46,470
-
-
Prepaid expenses and other current assets
176,771
169,049
-943,698
1,419,692
Accounts payable
-60,843
-510,181
-619,298
1,873,710
Accrued expenses
-147,399
-1,086,890
-1,376,990
-1,031,094
Contract liabilities
-
-
-12,000
-
Operating lease liability
-
-
0
0
Other liabilities
44,288
-12,770
-
-
Net cash used in operating activities
-5,992,214
-9,105,949
-9,005,821
-3,097,977
Cash paid for purchases of property and equipment
5,242
-
4,113,253
0
Cash paid for acquisition of controlling financial interest in orbit, net of cash acquired
0
540,915
-
-
Payment related to syme inventory advance (related party)
-
-
5,268,545
400,000
Cash paid for lyocon acquisition, net of cash acquired
0
749,905
-
-
Payments under convertible notes receivable (nil and 150,000, respectively, with related parties)
2,436,365
18,075,510
2,197,478
2,307,394
Advance on tekne convertible receivable
-
-
1,179,686
-
Net cash used in investing activities
-2,441,607
-19,366,330
-12,758,962
-2,707,394
Proceeds from note borrowings
-
-
23,250,000
1,757,000
Repayments of debt
7,912,419
1,712,314
433,333
1,650,001
Proceeds received from the offering
-
-
-
11,994,834
Proceeds received from the 2025 offering
-
-
11,994,834
-
Proceeds received from the february 2026 offering
0
11,994,929
-
-
Proceeds received from the sepa
8,823,764
2,172,771
20,107,033
1,830,853
Payments of debt and equity issuance costs
18,498
1,137,116
2,439,002
1,658,319
Proceeds received from settlement
-
-
0
0
Restricted stock units withheld for tax withholdings
-
-
173
-217
Proceeds from exercise of warrants
1,043
764,018
-
-
Net cash provided by financing activities
893,890
12,082,288
40,484,525
12,510,964
Effect of exchange rate changes on cash
-245
-4,183
-
-
Net change in cash and cash equivalents and restricted cash during the period
-7,540,176
-16,394,174
18,719,742
6,607,346
Cash and cash equivalents and restricted cash - beginning of period
9,142,251
25,536,425
6,816,683
209,337
Cash and cash equivalents and restricted cash - end of period
1,602,075
9,142,251
25,536,425
6,816,683
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.